Pharmalicensing… An elegant way of getting in touch with partners, René van der Linden, Pantarhei Bioscience.

‘Easily accessible’ and ‘not too expensive’ are the two of the main reasons behind Pantarhei Bioscience's decision to join Pharmalicensing and subscribe to the managed partnering service in early 2007.

Following its addition to the site, Pantarhei Bioscience has received a number of partnering enquiries by posting its licensing opportunities and has submitted a development project for the dedicated partner search which is included in the managed service subscription.

Pantarhei Bioscience of the Netherlands is committed to the development of innovative, patent protected, new treatment concepts and medical uses of existing compounds (biologicals, hormones, and drugs) based in the area of gender-related medicine.

Here at Pharmalicensing we spoke to René van der Linden, Director of Business Development at Pantarhei Bioscience, to find out what he thinks of the service and how he uses it. ‘Every other week I look for new opportunities on the website and in the newsletter, Pharmalicensing is different to other companies in that it is more active, many partnering companies are just databases, but Pharmalicensing offers that additional personal service.’ René told us.

René takes care of most of the business development and licensing activities of Pantarhei Bioscience therefore doesn’t have a lot of time to go searching for partners, especially when a visit to the company is required, but with Pharmalicensing the searching time is shortened ‘Pharmalicensing is an elegant way of getting in touch with partners, including some that you’ve never heard of before’ René declared.

Pleasing partner search results

A well known highlight of the managed partnering service is the partner search. The Pharmalicensing team recently conducted the partner search for Pantarhei Bioscience and René was very pleased with the results, so much so that he wanted another search carrying out. René spoke of his surprise in the results ‘From the list of target companies I knew 60/70% of the companies however the rest I didn’t even know’ the results have no doubt led to some good discussions for Pantarhei Bioscience.

René is also pleased with the regular quarterly statistics reports that are received as part of the managed partnering service. The quarterly statistics report provides an overall summary of the client’s performance on the Pharmalicensing website for the latest quarter of that year.

To make any comments on this article, or to ask a question of the author, please contact the publisher. If you would like to submit an article, please contact the editors.

The opinions expressed in the articles published in this section do not necessarily reflect those of Pharmalicensing or UTEK Corporation. No actions including proposals to or agreements with other companies should be taken by any reader without obtaining specific business or legal advice. Neither the publisher nor the authors accept any liability for any actions or activities undertaken by any reader or other third party as a consequence of these articles or for any errors or omissions therein.